Safety Information
Last Updated: August 31, 2026
Overview
This page provides important safety information for all medications and treatments available through MOY Health. Please read this information carefully before starting any treatment. This information does not replace the clinical guidance of your licensed physician.
If you are experiencing a medical emergency, call 911 immediately. For safety reporting, contact FDA MedWatch at 1-800-FDA-1088 or visit fda.gov/medwatch.
Compounded Medications Disclosure
All medications prescribed through MOY Health may be compounded by licensed U.S. pharmacies. Compounded medications are not approved by the U.S. Food and Drug Administration (FDA) and have not undergone FDA review for safety, effectiveness, or manufacturing quality. Compounded medications may still be lawfully prescribed when a licensed physician determines they are clinically appropriate following a medical consultation.
Eligibility
You may qualify for treatment through MOY Health if:
Your BMI is 30 or higher, or
Your BMI is 27 or higher with at least one weight-related health condition such as high blood pressure, type 2 diabetes, elevated cholesterol, obstructive sleep apnea, or cardiovascular disease.
If your BMI is above 25 you may still qualify depending on your overall medical history. Eligibility is assessed on an individual basis by a licensed physician.
Semaglutide
What it is:
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used for chronic weight management in combination with a reduced-calorie diet and increased physical activity.
Who should not use semaglutide:
Individuals with a personal or family history of medullary thyroid carcinoma (MTC)
Individuals with Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
Individuals who are pregnant, planning to become pregnant, or breastfeeding
Individuals with a known allergy to semaglutide or any of its ingredients
Individuals currently taking other GLP-1 receptor agonists
Common side effects:
Nausea, vomiting, diarrhea, constipation, abdominal pain
Headache, fatigue, dizziness
Decreased appetite
Injection site reactions
Serious but rare side effects:
Pancreatitis. Stop treatment and contact your physician right away if you have severe abdominal pain
Gallbladder disease including gallstones
Kidney problems in patients who experience severe vomiting or diarrhea
Increased heart rate
Suicidal thoughts or behaviors. Contact your physician or call or text 988 right away
Tirzepatide
What it is:
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist used for chronic weight management.
Who should not use tirzepatide:
Individuals with a personal or family history of medullary thyroid carcinoma (MTC)
Individuals with Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
Individuals who are pregnant, planning to become pregnant, or breastfeeding
Individuals with a known allergy to tirzepatide or any of its ingredients
Common side effects:
Nausea, vomiting, diarrhea, constipation, abdominal pain
Decreased appetite, fatigue, injection site reactions
Serious but rare side effects:
Pancreatitis, gallbladder disease, kidney problems, increased heart rate
Suicidal thoughts or behaviors. Contact your physician or call or text 988 right away
Sermorelin
What it is:
Sermorelin is a synthetic peptide that stimulates the pituitary gland to produce and release growth hormone naturally.
Who should not use sermorelin:
Individuals with active cancer or a history of cancer, unless cleared by their physician
Individuals with hypothyroidism that is not adequately treated
Individuals who are pregnant or breastfeeding
Individuals with known allergy to sermorelin or GHRH
Common side effects:
Injection site reactions, flushing, headache, dizziness, nausea
NAD+
What it is:
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in every cell that plays a role in energy metabolism. NAD+ prescribed through MOY Health is a compounded medication. It is not approved by the FDA for any condition.
Who should not use NAD+:
Individuals who are pregnant, planning to become pregnant, or breastfeeding
Individuals with a known allergy to NAD+ or any of its ingredients
Individuals with active cancer or a history of cancer, unless cleared by their physician
Individuals with significant liver or kidney disease, unless cleared by their physician
Common side effects:
Injection site redness, pain or swelling, flushing, nausea, stomach discomfort, headache, fatigue and dizziness.
When to get help:
Contact your physician if side effects continue or get worse. Call 911 if you have signs of a severe allergic reaction, such as swelling of the face or throat or difficulty breathing.
When to Call 911
Call 911 immediately if you experience a severe allergic reaction, chest pain, difficulty breathing, signs of pancreatitis, loss of consciousness, or any medical emergency.
Mental Health
If you experience suicidal thoughts or thoughts of self-harm at any time during treatment, seek immediate support. Call or text 988 to reach the Suicide and Crisis Lifeline. Call 911 if you are in immediate danger.
Contact Information
For questions about your treatment or to report a side effect:
Arilon Corp (d/b/a MOY Health)
30 N Gould St Ste R
Sheridan, WY 82801
support@trymoy.com
(307) 218-3882
For FDA safety reporting: 1-800-FDA-1088 or fda.gov/medwatch